tiprankstipranks
Trending News
More News >
Vivos Therapeutics (VVOS)
NASDAQ:VVOS
US Market

Vivos Therapeutics (VVOS) Financial Statements

Compare
206 Followers

Vivos Therapeutics Financial Overview

Vivos Therapeutics's market cap is currently $13.13M. The company's EPS TTM is $-0.45; its P/E ratio is ―; Vivos Therapeutics is scheduled to report earnings on May 15, 2025, and the estimated EPS forecast is $-0.39. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 15.03M$ 13.80M$ 16.02M$ 16.89M$ 13.07M
Gross Profit$ 9.02M$ 8.27M$ 10.02M$ 12.60M$ 10.41M
Operating Income$ -11.17M$ -17.30M$ -25.03M$ -19.47M$ -8.71M
EBITDA$ -10.55M$ -16.68M$ -24.36M$ -19.54M$ -11.24M
Net Income$ -11.14M$ -13.58M$ -22.66M$ -20.29M$ -8.82M
Balance Sheet
Cash & Short-Term Investments$ 6.26M$ 1.64M$ 3.52M$ 24.03M$ 18.21M
Total Assets$ 15.28M$ 10.73M$ 13.72M$ 33.69M$ 25.33M
Total Debt$ 1.51M$ 2.00M$ 2.41M$ 1.63M$ 1.29M
Net Debt$ -4.75M$ 352.00K$ -1.11M$ -22.40M$ -16.92M
Total Liabilities$ 7.33M$ 10.32M$ 8.92M$ 8.15M$ 8.41M
Stockholders' Equity$ 7.95M$ 411.00K$ 4.80M$ 25.54M$ 16.92M
Cash Flow
Free Cash Flow$ -13.26M$ -12.75M$ -20.51M$ -18.13M$ -5.80M
Operating Cash Flow$ -12.69M$ -11.95M$ -19.59M$ -15.73M$ -5.68M
Investing Cash Flow$ -568.00K$ -853.00K$ -924.00K$ -2.61M$ -120.25K
Financing Cash Flow$ 17.88M$ 10.92M$ 0.00$ 24.17M$ 23.54M
Currency in USD

Vivos Therapeutics Earnings and Revenue History

Vivos Therapeutics Debt to Assets

Vivos Therapeutics Cash Flow

Vivos Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis